Stay Informed on New Clinical Trials
Promising Results
Announced at AACR
The Ivy Brain Tumor Center at Barrow Neurological Institute announced initial results from a Phase 0/1b clinical trial of AZD1390, in combination with radiation therapy, in newly diagnosed, MGMT-unmethylated glioblastoma. Results from this study will be presented by Dr. Nader Sanai at the American Association for Cancer Research Annual Meeting and demonstrate that AZD1390 may be a potent radiosensitizer in both newly diagnosed and recurrent glioblastoma patients.
Clinical Trials at the Ivy Center
When a patient is referred to a clinical trial at the Ivy Brain Tumor Center, we partner with their physicians and treatment team on a path forward. While assessing a patient’s suitability for our clinical trials program, our dedicated team supports the physicians managing these cases. We work in partnership to create a patient-centered path forward.
Novel study designs aimed at assessing blood-brain barrier (BBB) penetration
Large portfolio of clinical trials investigating targeted therapies
Complimentary clinical trial screening for your patients
Collaborative partnerships with referring physicians
Is Your Patient Eligible?
Download our clinical trial overview sheet to discover if our trials offer a potential treatment option for your patients.
Download Now